Neoadjuvant
Oncology
4 drugs in development·4 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| opdivo qvantig | BRISTOL MYERS SQUIBB CO (BMY) |
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Toripalimab | Filana Therapeutics Inc. (FLNA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Neoadjuvant?
BioSniper tracks 4 drugs in development for Neoadjuvant across 4 companies.
How many clinical trials target Neoadjuvant?
There are 2 clinical trials targeting Neoadjuvant tracked by BioSniper.
Deep-dive into Neoadjuvant
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis